BCAL Diagnostics Limited Share Price
Equities
BDX
AU0000160921
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.091 AUD | -1.09% | -4.21% | -8.08% |
03-06 | BCAL Diagnostics Appoints CEO | MT |
02-20 | BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2024 * | 2.7M 1.75M 140M | Sales 2025 * | 2.5M 1.62M 130M | Capitalization | 23.21M 15.01M 1.2B |
---|---|---|---|---|---|
Net income 2024 * | -4M -2.59M -207M | Net income 2025 * | -6M -3.88M -311M | EV / Sales 2024 * | 7.52 x |
Net cash position 2024 * | 2.9M 1.88M 150M | Net cash position 2025 * | 2.7M 1.75M 140M | EV / Sales 2025 * | 8.2 x |
P/E ratio 2024 * |
-5.11
x | P/E ratio 2025 * |
-4.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.25% |
1 day | -1.09% | ||
1 week | -4.21% | ||
Current month | -13.33% | ||
1 month | -13.33% | ||
6 months | -7.14% | ||
Current year | -8.08% |
Managers | Title | Age | Since |
---|---|---|---|
Shane Ryan
CEO | Chief Executive Officer | - | 20/09/23 |
Guy Robertson
DFI | Director of Finance/CFO | 70 | - |
Chief Tech/Sci/R&D Officer | - | 31/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Jayne Shaw
FOU | Founder | - | 31/12/09 |
Director/Board Member | 75 | 13/02/22 |
Date | Price | Change | Volume |
---|---|---|---|
01/05/24 | 0.091 | -1.09% | 464 849 |
30/04/24 | 0.092 | 0.00% | 236,385 |
29/04/24 | 0.092 | -3.16% | 210,016 |
24/04/24 | 0.095 | 0.00% | 155,000 |
23/04/24 | 0.095 | 0.00% | 110,556 |
Delayed Quote Australian S.E., May 01, 2024 at 03:47 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.08% | 15.23M | |
-0.60% | 12.95B | |
-9.59% | 7.84B | |
+1.82% | 5.5B | |
+0.02% | 4.61B | |
+7.32% | 4.61B | |
-47.68% | 3.4B | |
+6.42% | 2.66B | |
-14.59% | 2.08B | |
+2.25% | 1.79B |
- Stock Market
- Equities
- BDX Stock